摘要
BackgroundThe size of lymph node metastasis (LNM) and pre-ablation stimulated Tg (ps-Tg) were key predictors of clinical prognosis in differentiated thyroid cancer (DTC) patients, however, very few studies combine the above two as predictors of clinical prognosis of DTC patients. MethodsPersistent/recurrent disease and clinicopathologic factors were analyzed in 543 DTC patients without distant metastases who underwent LN dissection, near-total/total thyroidectomy, and radioiodine ablation. ResultsIn the multivariate analysis, size of LNM, ps-Tg, and the activity of I-131 significantly correlated with long-term remission. The optimal cutoff size of LNM 0.4 cm-1.4 cm (intermediate-risk patients) and >1.4cm (high-risk patients) increased the recurrence risk (hazard ratio [95% CI], 4.674 [2.881-7.583] and 13.653 [8.135-22.913], respectively). Integration of ps-Tg into the reclassification risk stratification showed that ps-Tg <= 10.0 ng/mL was relevant to a greatly heightened possibility of long-term remission (92.2%-95.4% in low-risk patients, 67.3%-87.0% in intermediate-risk patients, and 32.3%-57.7% in high-risk patients). ConclusionThe cutoff of 0.4 cm and 1.4 cm for a definition of size of LNM in DTC patients without distant metastases can reclassify risk assessment, and incorporating ps-Tg could more effectively predict clinical outcomes and modify the postoperative management plan.
学科与关键词
- Incorporation size of lymph node metastasis focus and pre-ablation stimulated Tg could more effectively predict clinical outcomes in differentiated thyroid cancer patients without distant metastases (vol 14, 1094339, 2023)Xie, Jiahao; Chen, Pan; Wang, Jing; Luo, Xiaoqin; Luo, Jiaxin; Xiong, Xiaoli; Li, Chunyan; Pan, Liqin; Wu, Juqing; Feng, Huijuan; Ouyang, Wei*Frontiers in Endocrinology, 2023, 14: 1221004.
- Preoperative serum thyroglobulin is a risk factor of skip metastasis in papillary thyroid carcinomaHuang, Ziyang; Song, Muye; Wang, Shujie; Huang, Jianhao; Shi, Hongyan; Huang, Yijie; Yin, Ying; Liu, Yongchen*; Wu, Zeyu*Annals of Translational Medicine, 2020, 8(6): 389.被引 9
- High Ki-67 LI is an Important Factor for Good Early Outcomes After Radioiodine Therapy in Patients with Intermediate to High-Risk Papillary Thyroid CancerLuo, X.; Ouyang, W.Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), Vienna, AUSTRIA, 2023-09-09 To 2023-09-13.
